MTOR and renal cell carcinoma: And mTOR pathway inhibitors induced MAPK escape cell death and cells became resistant to mTOR inhibitors, and then the combination of mTOR and MAPK inhibitors would get better treatment and outcome for RCC patients (Chauhan et al., 2016).